Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pre-Surgical Window of Opportunity Trial Investigating the Effect of Cyclosporin A on Triple Negative Breast Cancer With Defective DNA Repair

NCT06246786 is registered in ClinicalTrials.gov with Virginia G. Kaklamani as lead sponsor.

NCT NCT06246786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06246786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pre-Surgical Window of Opportunity Trial Investigating the Effect of Cyclosporin A on Triple Negative Breast Cancer With Defective DNA Repair
Lead sponsor
Virginia G. Kaklamani
Phase
Phase 1
Overall status
Withdrawn
Start date
July 1, 2024
Completion date
June 23, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dna damage repair deficiency, triple negative breast cancer